2187 |
Update 2013: IVUS-guided Optimization of PCI |
Gary S. Mintz |
May. 09. 13 |
2186 |
Now, Do the IVUS-MLA Criteria Need to Be Adjusted ? |
Seung-Jung Park |
May. 09. 13 |
2185 |
Can IVUS Predict FFR? Lessons from VERDICT and F1RST |
Ron Waksman |
May. 09. 13 |
2184 |
Validation and Application of IVUS-MLA in LMCA Disease |
Jose M De la Torre Hernandez |
May. 09. 13 |
2183 |
Pathologic Insights into Vulnerable Plaque |
Gaku Nakazawa |
May. 09. 13 |
2182 |
[Does Morphology Predict Future Events?] Con: No, It Is Not Enough |
Soo-Jin Kang |
May. 09. 13 |
2181 |
[Does Morphology Predict Future Events?] Pro: Yes, Insights from PROSPECT |
Akiko Maehara |
May. 09. 13 |
2180 |
Current Status of CT for Plaque Evaluation |
Wm. Guy Weigold |
May. 09. 13 |
2179 |
What Is the Role of CT Imaging in Risk Stratification? |
Joon-Won Kang |
May. 09. 13 |
2178 |
WATCHMAN Single Center Experience with Focus on TEE-guided Transseptal Puncture |
Teguh Santoso |
May. 09. 13 |